We have data on 107 companies that use SnpEff. The companies using SnpEff are most often found in United States and in the Higher Education industry. SnpEff is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for SnpEff usage goes back as far as 4 years and 11 months.
Company | Regeneron Pharmaceuticals Inc |
Website | regeneron.com |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | Arizona State University |
Website | asu.edu |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | University of Arizona |
Website | arizona.edu |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | U.S. Department of Agriculture |
Website | usda.gov |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | International Business Machines Corporation |
Website | ibm.com |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | Website | Country | Revenue | Company Size |
---|---|---|---|---|
Regeneron Pharmaceuticals Inc | regeneron.com | United States | >1000M | >10000 |
Arizona State University | asu.edu | United States | >1000M | >10000 |
University of Arizona | arizona.edu | United States | >1000M | >10000 |
U.S. Department of Agriculture | usda.gov | United States | >1000M | >10000 |
International Business Machines Corporation | ibm.com | United States | >1000M | >10000 |
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, SnpEff has a market share of about 0.1%. Other major and competing products in this category include:
SnpEff is an open source tool that annotates variants and predicts their effects on genes by using an interval forest approach. This program takes pre-determined variants listed in a data file that contains the nucleotide change and its position and predicts if the variants are deleterious.
Looking at SnpEff customers by industry, we find that Higher Education (27%), Biotechnology (24%), Hospital & Health Care (13%) and Research (8%) are the largest segments.
67% of SnpEff customers are in United States and 7% are in India.
Of all the customers that are using SnpEff, a majority (57%) are large (>1000 employees), 15% are small (<50 employees) and 20% are medium-sized.
Of all the customers that are using SnpEff, a majority (55%) are large (>$1000M), 27% are small (<$50M) and 9% are medium-sized.